| Normalizing the environment recapitulates adult human immune traits in laboratory mice LK Beura, SE Hamilton, K Bi, JM Schenkel, OA Odumade, KA Casey, ... Nature 532 (7600), 512-516, 2016 | 1072 | 2016 |
| Signals required for programming effector and memory development by CD8+ T cells MF Mescher, JM Curtsinger, P Agarwal, KA Casey, M Gerner, ... Immunological reviews 211 (1), 81-92, 2006 | 855 | 2006 |
| Dynamic T cell migration program provides resident memory within intestinal epithelium D Masopust, D Choo, V Vezys, EJ Wherry, J Duraiswamy, R Akondy, ... Journal of Experimental Medicine 207 (3), 553-564, 2010 | 723 | 2010 |
| Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues KA Casey, KA Fraser, JM Schenkel, A Moran, MC Abt, LK Beura, ... The Journal of Immunology 188 (10), 4866-4875, 2012 | 686 | 2012 |
| Programming for CD8 T cell memory development requires IL-12 or type I IFN Z Xiao, KA Casey, SC Jameson, JM Curtsinger, MF Mescher The Journal of Immunology 182 (5), 2786-2794, 2009 | 303 | 2009 |
| Memory CD8 T-cell compartment grows in size with immunological experience V Vezys, A Yates, KA Casey, G Lanier, R Ahmed, R Antia, D Masopust Nature 457 (7226), 196-199, 2009 | 272 | 2009 |
| IL-15–independent maintenance of tissue-resident and boosted effector memory CD8 T cells JM Schenkel, KA Fraser, KA Casey, LK Beura, KE Pauken, V Vezys, ... The Journal of Immunology 196 (9), 3920-3926, 2016 | 189 | 2016 |
| Dendritic cell and antigen dispersal landscapes regulate T cell immunity MY Gerner, KA Casey, W Kastenmuller, RN Germain Journal of Experimental Medicine 214 (10), 3105-3122, 2017 | 176 | 2017 |
| IL-21 promotes differentiation of naive CD8 T cells to a unique effector phenotype KA Casey, MF Mescher The Journal of Immunology 178 (12), 7640-7648, 2007 | 158 | 2007 |
| Self-reactive IgE exacerbates interferon responses associated with autoimmunity J Henault, JM Riggs, JL Karnell, VM Liarski, J Li, L Shirinian, L Xu, ... Nature immunology 17 (2), 196-203, 2016 | 157 | 2016 |
| Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus S Rahman, D Sagar, RN Hanna, YL Lightfoot, P Mistry, CK Smith, ... Annals of the rheumatic diseases 78 (7), 957-966, 2019 | 149 | 2019 |
| Defective MHC class II presentation by dendritic cells limits CD4 T cell help for antitumor CD8 T cell responses MY Gerner, KA Casey, MF Mescher The Journal of Immunology 181 (1), 155-164, 2008 | 95 | 2008 |
| Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus JL Karnell, Y Wu, N Mittereder, MA Smith, M Gunsior, L Yan, KA Casey, ... Science translational medicine 13 (595), eabf8442, 2021 | 74 | 2021 |
| Type I interferon receptor blockade with anifrolumab corrects innate and adaptive immune perturbations of SLE KA Casey, X Guo, MA Smith, S Wang, D Sinibaldi, MA Sanjuan, L Wang, ... Lupus Science & Medicine 5 (1), e000286, 2018 | 72 | 2018 |
| Molecular basis for checkpoints in the CD8 T cell response: tolerance versus activation MF Mescher, P Agarwal, KA Casey, CD Hammerbeck, Z Xiao, ... Seminars in immunology 19 (3), 153-161, 2007 | 68 | 2007 |
| Modulation of cardiometabolic disease markers by type I interferon inhibition in systemic lupus erythematosus KA Casey, MA Smith, D Sinibaldi, NL Seto, MP Playford, X Wang, ... Arthritis & Rheumatology 73 (3), 459-471, 2021 | 54 | 2021 |
| Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus K Hudspeth, S Wang, J Wang, S Rahman, MA Smith, KA Casey, ... Clinical & Experimental Immunology 196 (2), 226-236, 2019 | 34 | 2019 |
| SLE plasma profiling identifies unique signatures of lupus nephritis and discoid lupus MA Smith, J Henault, JL Karnell, ML Parker, JM Riggs, D Sinibaldi, ... Scientific reports 9 (1), 14433, 2019 | 23 | 2019 |
| Using the circulating proteome to assess type I interferon activity in systemic lupus erythematosus MA Smith, CC Chiang, K Zerrouki, S Rahman, WI White, K Streicher, ... Scientific Reports 10 (1), 4462, 2020 | 22 | 2020 |
| The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeys SM Nicholson, KA Casey, M Gunsior, S Drabic, W Iverson, H Cook, ... British Journal of Pharmacology 177 (5), 1061-1076, 2020 | 15 | 2020 |
David Masopust PhDUniversity of MinnesotaVerified email at umn.edu
